Show simple item record

Anti-platelet drugs and their necessary interaction with endothelial mediators and platelet cyclic nucleotides for therapeutic efficacy

dc.contributor.authorKnowles, RBen_US
dc.contributor.authorWarner, TDen_US
dc.date.accessioned2019-02-21T16:28:36Z
dc.date.issued2019-01en_US
dc.identifier.issn0163-7258en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/55461
dc.description.sponsorshipThis work was supported by the British Heart Foundation [FS/12/53/29643] to RBK.en_US
dc.format.extent83 - 90en_US
dc.language.isoenen_US
dc.relation.ispartofPHARMACOLOGY & THERAPEUTICSen_US
dc.rightsCreative Commons Attribution License
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subjectPlateleten_US
dc.subjectEndotheliumen_US
dc.subjectDual antiplatelet therapyen_US
dc.subjectThrombosisen_US
dc.subjectCyclic nucleotideen_US
dc.titleAnti-platelet drugs and their necessary interaction with endothelial mediators and platelet cyclic nucleotides for therapeutic efficacyen_US
dc.typeArticle
dc.rights.holder2018. The authors
dc.identifier.doi10.1016/j.pharmthera.2018.08.004en_US
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000456227400007&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.notesNo embargoen_US
pubs.publication-statusPublisheden_US
pubs.volume193en_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US
qmul.funderInteractions between aspirin and new generation P2Y12 receptor antagonists::British Heart Foundationen_US


Files in this item

Thumbnail
Name:
Knowles & Warner. 2018. Anti-p ...
Size:
822.1Kb
Format:
application/
Description:
Published version
View/Open
Thumbnail
Name:
license_rdf
Size:
914bytes
Format:
application/rdf+xml
View/Open

This item appears in the following Collection(s)

Show simple item record

Creative Commons Attribution License
Except where otherwise noted, this item's license is described as Creative Commons Attribution License